Ami Asset Management Corp Corcept Therapeutics Inc Transaction History

Ami Asset Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 23, 2020	SELL	$12.06 - $16.96 $9.35 Million - $13.2 Million	-775,685 Closed	0 $0
Q3 2019 Oct 23, 2019	SELL	$10.41 - $14.66 $1.34 Million - $1.88 Million	-128,435 Reduced 14.21%	775,685 $11 Million
Q2 2019 Aug 05, 2019	BUY	$9.78 - $12.76 $1.77 Million - $2.31 Million	181,188 Added 25.06%	904,120 $10.1 Million
Q1 2019 Apr 25, 2019	SELL	$10.03 - $15.71 $319,686 - $500,724	-31,873 Reduced 4.22%	722,932 $8.49 Million
Q4 2018 Jan 25, 2019	BUY	$11.29 - $17.19 $1.42 Million - $2.16 Million	125,444 Added 19.93%	754,805 $10.1 Million
Q3 2018 Oct 23, 2018	SELL	$12.27 - $15.65 $652,874 - $832,720	-53,209 Reduced 7.8%	629,361 $8.82 Million
Q2 2018 Jul 23, 2018	SELL	$15.3 - $19.69 $408,969 - $526,313	-26,730 Reduced 3.77%	682,570 $10.7 Million
Q1 2018 Apr 20, 2018	BUY	$14.59 - $25.5 $1.22 Million - $2.14 Million	83,918 Added 13.42%	709,300 $11.7 Million
Q4 2017 Jan 16, 2018	BUY	$15.77 - $20.72 $1.54 Million - $2.03 Million	97,867 Added 18.55%	625,382 $11.3 Million
Q3 2017 Oct 10, 2017	BUY	$12.3 - $19.3 $6.49 Million - $10.2 Million	527,515	527,515 $10.2 Million

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Ami Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Ami Asset Management Corp with notifications on news.